We are delighted to be featured on the 2024 edition of The Sunday Times Hundred, Britain's fastest-growing private companies. The league table takes on the baton from The Sunday Times Fast Track 100 series, which celebrated the country's leading entrepreneurs for 24 years. See the list here: https://lnkd.in/e_ufZH-U
Cycle Pharmaceuticals
Pharmaceutical Manufacturing
Cambridge, Cambridgeshire 9,264 followers
Every Single Patient Matters.
About us
We’re committed to supporting patients and their caregivers in every way we can. They are at the heart of everything we do. We focus on providing treatments and services for patients with neurological, rare metabolic, and rare immunological conditions, most of which are genetic conditions. We’re headquartered in Cambridge, UK and have staff working across the US, with an office in Boston, MA.
- Website
-
http://www.cyclepharma.com/
External link for Cycle Pharmaceuticals
- Industry
- Pharmaceutical Manufacturing
- Company size
- 51-200 employees
- Headquarters
- Cambridge, Cambridgeshire
- Type
- Privately Held
- Founded
- 2012
- Specialties
- Rare Diseases, Pharmaceutical Industry, Formulation technology, Patient centric, Innovation, Research and Development, Tyrosinemia, Neurology, immunology , Multiple Sclerosis, HAE, PKU, MS, and cystineria
Locations
-
Primary
The Broers Building
21 JJ Thomson Avenue
Cambridge, Cambridgeshire CB3 0FA, GB
-
Boston, US
Employees at Cycle Pharmaceuticals
Updates
-
We’d like to introduce our Supply Chain Manager, David. “The area I am most passionate about is the Free Goods Programme. We are providing treatments to people who could never afford it under normal circumstances and usually in places where no other versions of these treatments are available.” #MeetTheTeam
-
-
The wait is over… We’re thrilled to share James' Be Inspired episode with the LSEG (London Stock Exchange Group)! In this interview James shares how Cycle started, why we do what we do, and his personal career journey. Watch the full episode here: https://lnkd.in/eNDe9uuZ Or listen on your preferred podcast platform including Apple and Spotify by searching ‘London Stock Exchange’.
Cycle Pharmaceuticals: Transforming the lives of patients with rare diseases | Be Inspired
https://www.youtube.com/
-
We will be headed to the SERGG Annual Meeting, the IWAA Annual Scientific Session, and the National PKU Alliance Conference this month. Be sure to stop by our booths and say hello if you’re attending, we’d love to see you!
-
-
Did you know that patients with cystinuria are recommended to closely control their diet? Specifically, they’re recommended to reduce their salt and methionine (an amino acid found in meat, fish, and dairy products) intake, as this can have an impact on the likelihood of kidney stones forming. And did you know that our patient support program, Cycle Vita, offers a Patient Nutrition Program* to eligible patients, which reinforces the clinic’s nutrition program? Learn more about this treatment option and our patient support program in our press release: https://ow.ly/hVfm50SaKjR #Cystinuria #RareDisease #KidneyStones *Some areas of support may not be accessible to all patients. Eligibility criteria may apply to ensure compliance with all applicable federal and state requirements, and benefits may be limited to commercially insured patients only. For more detailed information about eligibility, terms and conditions, please contact the Cycle Vita team at +1 (888) 360-8482.
-
-
Did you know we offer a treatment for patients in the US with Primary Periodic Paralysis (PPP)? Watch the video to find out what PPP is. You can watch more videos from Dr Santoro at https://lnkd.in/ekZcVzUY These videos cover: 🟣 The Symptoms of PPP 🟣 Diagnosing PPP 🟣 The Patient Journey These videos are intended for healthcare providers and Dr Santoro was compensated for his services.
-
Cycle Pharmaceuticals reposted this
So proud that Cycle Pharmaceuticals is in the 2024 #SundayTimes100 list of the UK's fastest growing businesses. Shout out to the whole Cycle team. Shout out to everyone who has helped us on this incredible journey. Let's go again and help more and more people born with rare genetic diseases. "we've not come this far, to come this far"! David Buckeridge Steve Fuller Steve McCue Sarah Gowing Chikai Lai Romina Briffa, PhD Catherine Wainwright Chris Shaw Zac Bohlen #eoyuk Sumir Karayi Ally Scott Frank O'Keeffe Lynn Rattigan Courtney Shields Tim Davis Richard Tyler Ying van de Walle
-
-
Today is International #PKUDay. A day to raise awareness for Phenylketonuria, commonly known as PKU. PKU is a #RareGeneticDisorder that prevents the body from properly breaking down an amino acid called phenylalanine, found in many protein-containing foods. Without proper management this amino acid can build up in the blood and lead to serious health issues. Understanding PKU helps support those living with the disorder and their caregivers. Why June 28th? PKU Day takes place on June 28th because both Robert Gurthrie and Horst Bickel were born on this day in 1916 and 1918 respectively. Robert Gurthrie invented the possibility for newborn screening – also known as the “Guthrie test”. Horst Bickel was the firs to develop a low-protein diet for PKU and establish screening in Germany. To learn more about PKU and the importance of spreading awareness visit: https://lnkd.in/gHkpcSP
-
-
For our #MeetTheTeam post this month we’d like to introduce you to Rosie Collings who is part of our Regulatory Affairs team. “Knowing that my role makes a difference to patients and their families, contributing to patients’ safety is what gets me out of bed everyday ready to work.”
-
-
On Friday, James was interviewed by Dame Julia Hoggett, CEO of the London Stock Exchange at their headquarters in London. Be on the lookout for the video and podcast with the LSEG (London Stock Exchange Group) as part of their ‘Be Inspired’ #CEOseries. Here’s a glimpse behind the scenes!🎥
-